Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
A case study of nephrologists examines physicians' attitudes towards patients in advanced stages of kidney disease and how these attitudes affect the end-of-life care the patient receives.